Reasons why Rover Group Inc.’s (NASDAQ:ROVR) fundamentals are futile
In yesterday’s Wall Street session, Rover Group Inc. (NASDAQ:ROVR) shares traded at $5.58, up 1.82% from the previous session. 8 analysts cover Rover Group Inc. (NASDAQ:ROVR), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $7.00 and a […]
An overview of Apollo Commercial Real Estate Finance Inc.’s (ARI) institutional holdings
The price of Apollo Commercial Real Estate Finance Inc. (NYSE:ARI) shares last traded on Wall Street fell -10.76% to $10.53. Based on available information, 7 analysts follow Apollo Commercial Real Estate Finance Inc. (NYSE:ARI). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high […]
How Do Lottery.com Inc. (NASDAQ:LTRY)’s Fundamentals Affect Performance
The price of Lottery.com Inc. (NASDAQ:LTRY) shares last traded on Wall Street rose 4.38% to $0.21. Based on available information, 1 analysts follow Lottery.com Inc. (NASDAQ:LTRY). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $14.00 and a low of $14.00, we […]
How should investors evaluate Syneos Health Inc. (NASDAQ:SYNH)?
Stocks of Syneos Health Inc. (NASDAQ:SYNH) traded higher last session on Wall Street, down -0.12% to $42.36. According to the data, Syneos Health Inc. (NASDAQ:SYNH) has 11 analysts covering its stock. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $43.00 and […]
Does Rambus Inc. (NASDAQ:RMBS) warrant a purchase right now? What to Consider Before Making a Decision
Rambus Inc. (NASDAQ:RMBS) shares traded -12.36% lower at $54.87 on Wall Street last session. In accordance with the data, 6 analysts cover Rambus Inc. (NASDAQ:RMBS). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $75.00 and a low of $65.00, we find […]
Can Brookdale Senior Living Inc. (BKD) stock recover despite sales dropping?
In yesterday’s Wall Street session, Brookdale Senior Living Inc. (NYSE:BKD) shares traded at $3.75, up 6.53% from the previous session. 4 analysts cover Brookdale Senior Living Inc. (NYSE:BKD), according to research data. The consensus rating among analysts is ‘Underweight’. As we calculate the median target price by taking the range between a high of $7.00 […]
Does WisdomTree Inc. (NYSE:WT) have deteriorating prospects?
WisdomTree Inc. (NYSE:WT) shares traded 3.11% higher at $6.96 on Wall Street last session. In accordance with the data, 7 analysts cover WisdomTree Inc. (NYSE:WT). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $10.00 and a low of $6.75, we find […]
There’s Still Time to Buy Verisk Analytics Inc. (NASDAQ:VRSK) Stock
In yesterday’s Wall Street session, Verisk Analytics Inc. (NASDAQ:VRSK) shares traded at $228.94, down -1.39% from the previous session. 19 analysts cover Verisk Analytics Inc. (NASDAQ:VRSK), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $260.00 and a […]
Do you still think Incyte Corporation (NASDAQ:INCY) is worth a look?
In yesterday’s Wall Street session, Incyte Corporation (NASDAQ:INCY) shares traded at $63.72, up 1.00% from the previous session. As of this writing, 22 analysts cover Incyte Corporation (NASDAQ:INCY). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $109.00 and a low of […]
The shares of BioMarin Pharmaceutical Inc. (BMRN) have recorded the market capitalization of 16.31B
The stock of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) last traded at $87.93, up 0.37% from the previous session. Data from the available sources indicates that BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is covered by 26 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]
